Healx is a technology company utilizing artificial intelligence to transform drug discovery for rare diseases. With approximately 10,000 rare diseases affecting around 400 million people worldwide, and a significant lack of approved treatments—over 90%—Healx is dedicated to addressing this urgent medical need. The company combines advanced data analytics, AI, and extensive pharmacological expertise to accelerate the development of new therapies, making the process quicker and more efficient than conventional methods. Founded in 2014 in Cambridge, UK, Healx has built a diverse and skilled team, creating a collaborative environment that fosters innovation and supports employee growth. The organization is committed to inclusivity and values unique perspectives that contribute to its mission of improving outcomes for rare disease patients.